Archives
Editorial | Physiotherapists can reduce overuse by Choosing Wisely.
23 Jun, 2021 | 10:11h | UTCPhysiotherapists can reduce overuse by Choosing Wisely – Journal of Physiotherapy
See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada
Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”.
22 Jun, 2021 | 10:08h | UTCIvermectin is the new hydroxychloroquine, take 2 – Science-Based Medicine
Related: [Preprint] Meta-analysis of RCT: Ivermectin for the treatment of COVID-19 – no effect on all-cause mortality, length of stay, or viral clearance AND M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection AND Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials AND EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomized clinical trials AND FDA: Why you should not use Ivermectin to treat or prevent COVID-19 AND RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19 AND NIH Guideline Statement: “there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19” AND Video (5min): Ivermectin for COVID-19 | A Doctor Explains
Perspective | COVID-19: The rise and rise of Delta.
22 Jun, 2021 | 10:10h | UTCCOVID-19: The rise and rise of Delta – Sciblogs
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
22 Jun, 2021 | 09:58h | UTC2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis – The Lancet Neurology (free registration required)
Commentary on Twitter
ONLINE FIRST: The 2021 MAGNIMS–CMSC–NAIMS international consensus recommendations on MRI in patients with multiple sclerosis provide updated guidance on how and when to use MRI for diagnosis, prognosis, and treatment monitoring of multiple sclerosishttps://t.co/bLnRo40tgw
— The Lancet Neurology (@TheLancetNeuro) June 15, 2021
Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances: The CONSERVE 2021 Statement.
22 Jun, 2021 | 10:04h | UTC
Commentaries on Twitter
CONSERVE offers guidance that could help improve the transparency, quality, and completeness of reporting important modifications to trials in extenuating circumstances https://t.co/IiWgs7dtpQ
— JAMA (@JAMA_current) June 21, 2021
https://twitter.com/DrSherryPagoto/status/1407102563191824384
Case report: Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection.
22 Jun, 2021 | 10:04h | UTC
AGS publishes updated AGS Minimum Geriatrics Competencies for Graduating Medical Students.
22 Jun, 2021 | 09:59h | UTCNews release: AGS publishes updated AGS Minimum Geriatrics Competencies for Graduating Medical Students – American Geriatrics Society
Recommendations: Minimum Geriatric Competencies for Medical Students
Study shows overuse of levothyroxine in patients with subclinical hypothyroidism despite evidence of no benefit.
22 Jun, 2021 | 09:57h | UTCLevothyroxine Use in the United States, 2008-2018 (free for a limited period)
Editorial: Overuse of Levothyroxine in Patients With Subclinical Hypothyroidism: Time to “Leve”-Out-Thyroxine – JAMA Internal Medicine (free for a limited period)
Related: RCT: Levothyroxine does not reduce the risk of developing depressive symptoms in older adults with subclinical hypothyroidism (studies and guidelines on the subject)
Guideline synopsis: management of blood pressure in patients with chronic kidney disease not receiving dialysis.
22 Jun, 2021 | 10:00h | UTCOriginal guideline: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
Commentary: Guideline issued on blood pressure management in CKD – ACP Internist
Expert analysis: the ever-growing role of coronary artery calcium in primary prevention.
22 Jun, 2021 | 09:54h | UTC
Commentary on Twitter
New ACC Expert Analysis: The Ever-Growing Role of Coronary Artery Calcium in Primary Prevention.
More: https://t.co/GSsEqkoMbi @miguelcainzos23 @rblument1 @AndyGagel #ASCVD #cvPrev pic.twitter.com/7cUOAIArz9
— American College of Cardiology (@ACCinTouch) June 22, 2021
Increased transmissibility and global spread of SARS-CoV-2 variants of concern – “Estimated transmissibility increases of alpha 29% (95% CI: 24–33), beta 25% (95% CI: 20–30), gamma 38% (95% CI: 29–48) & delta 97% (95% CI: 76–117)”.
21 Jun, 2021 | 08:55h | UTC
Commentary on Twitter
NEW publication in Eurosurveillance
Increased transmissibility & global spread of #SARSCoV2 VOC & VOI
Estimated transmissibility increases of alpha 29% (95% CI: 24–33), beta 25% (95% CI: 20–30), gamma 38% (95% CI: 29–48) & delta 97% (95% CI: 76–117)
⬇️https://t.co/pmyfQMM78y pic.twitter.com/Xz3cOImRvc
— Maria Van Kerkhove (@mvankerkhove) June 17, 2021
National surveillance in England showed low risk of reinfection with Covid-19 – “There were 15,893 possible reinfections with SARS-CoV-2 identified up to 30 May 2021 in England throughout the pandemic, out of nearly 4 million people with confirmed infections. This is equivalent to around 0.4% cases becoming reinfected”.
21 Jun, 2021 | 08:56h | UTCNew national surveillance of possible COVID-19 reinfection, published by PHE – Public Health England
Related: Had COVID? You’ll probably make antibodies for a lifetime – Nature AND COVID-19 reinfection rate less than 1 percent for those with severe illness, study finds. AND Study shows low risk of SARS-CoV-2 reinfection 1 year after primary infection.
WHO says delta is becoming the dominant Covid variant globally.
21 Jun, 2021 | 08:54h | UTCWHO says delta is becoming the dominant Covid variant globally – CNBC
Perspective | A beautiful idea: how COVAX has fallen short.
21 Jun, 2021 | 08:52h | UTCA beautiful idea: how COVAX has fallen short – The Lancet
Commentaries on Twitter
#COVAX was meant to supply #COVID19 vaccines for all based on solidarity and equity. Instead, it relies on rich countries' willingness to share their doses—Ann Danaiya Usher tracks the ambitions and shortcomings of COVAX: https://t.co/FbAZ1D8M4j #VaccinEquity pic.twitter.com/q880pzeU1s
— The Lancet (@TheLancet) June 19, 2021
#Vaccine doses given/100 inhabitants…🤔Rich countries praising solidarity by contributing to #COVAX while making sure that there is barely any #COVID19 vaccine left to be purchased through covax.
Check also @newhumanitarian: https://t.co/K1zzM6O3on pic.twitter.com/IpH0mDJqwC
— Tim Buder (@Tim_Buder) February 10, 2021
“COVAX has delivered over 72m doses to 125 countries. But that is far less than 172m it should have delivered by now. Of the 2.1 billion COVID-19 vaccine doses administered worldwide so far, COVAX has been responsible for less than 4%"#PeoplesVaccinehttps://t.co/TZKc8YPAdJ
— Steve Jackson 💙 (@SteJck) June 20, 2021
M-A: Azithromycin does not reduce the need for invasive mechanical ventilation or mortality in patients with Covid-19.
21 Jun, 2021 | 08:45h | UTC
Study: Sperm parameters not changed before and after COVID-19 mRNA vaccination.
21 Jun, 2021 | 08:50h | UTCSperm Parameters Before and After COVID-19 mRNA Vaccination – JAMA
Concerned about the latest AstraZeneca news? These 3 graphics help you make sense of the risk – “Two people in Australia have died from thrombosis with thrombocytopenia after 3.8 million doses of the AstraZeneca vaccine delivered”.
21 Jun, 2021 | 08:48h | UTC
Perspective | Sewage sleuths helped an Arizona town beat back Covid-19. For wastewater epidemiology, that’s just the start.
21 Jun, 2021 | 08:43h | UTCRelated: The myriad ways sewage surveillance is helping fight COVID around the world – Nature AND Testing sewage can give school districts, campuses and businesses a heads-up on the spread of COVID-19 – The Conversation AND It’s time to begin a national wastewater testing program for Covid-19 – STAT AND Coronavirus: Testing sewage an ‘easy win’ – BBC
Perspective | Human waste could be the next big weapon in controlling COVID-19.
21 Jun, 2021 | 08:42h | UTCHuman Waste Could Be The Next Big Weapon in Controlling COVID-19 – TIME
Related: The myriad ways sewage surveillance is helping fight COVID around the world – Nature AND Testing sewage can give school districts, campuses and businesses a heads-up on the spread of COVID-19 – The Conversation AND It’s time to begin a national wastewater testing program for Covid-19 – STAT AND Coronavirus: Testing sewage an ‘easy win’ – BBC
Risk of atrial fibrillation according to cancer type: a nationwide population-based study – Multiple myeloma showed a higher association with incident AF (aHR: 3.34; 95% CI: 2.98 to 3.75). Esophageal cancer showed the highest risk among solid cancers (aHR: 2.69; 95% CI: 2.45 to 2.95).
21 Jun, 2021 | 08:37h | UTC
Commentary on Twitter
Patients with #cancer have a higher risk of atrial fibrillation, and its impact varies according to the type of cancer. https://t.co/j84td0oRck #epeeps #JACCCardioOnc #ACCCardioOnc #CardioOnc #AFib #CKD #CVD #MMsm #lymsm #leusm #melanoma #OpenAccess pic.twitter.com/ebXJJ3zYYY
— JACC Journals (@JACCJournals) June 19, 2021
Africa’s COVID-19 surge is expected to worsen, warns WHO.
21 Jun, 2021 | 08:44h | UTCAfrica’s COVID-19 Surge is Expected to Worsen, Warns WHO – Health Policy Watch
One in 100 deaths is by suicide – WHO guidance to help the world reach the target of reducing suicide rate by 1/3 by 2030.
21 Jun, 2021 | 08:39h | UTCOne in 100 deaths is by suicide – World Health Organization
Report: Suicide worldwide in 2019: Global Health Estimates – World Health Organization
Commentary on Twitter (thread – click for more)
DYK: 1 in 100 deaths is by suicide.
Every year, more people die as a result of suicide than HIV, malaria or breast cancer – or war and homicide. https://t.co/PAD5Bd1dfS pic.twitter.com/TGq5BdNMNd
— World Health Organization (WHO) (@WHO) June 17, 2021
Consensus-based recommendations for management of the difficult airway: part 1. Difficult airway management encountered in an unconscious patient.
21 Jun, 2021 | 08:33h | UTC
AHA Scientific Statement: Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology.
21 Jun, 2021 | 08:38h | UTCTop Things to Know: Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology – American Heart Association
Review: Advances in the diagnosis and treatment of primary ciliary dyskinesia.
21 Jun, 2021 | 08:27h | UTCAdvances in the Diagnosis and Treatment of Primary Ciliary Dyskinesia: A Review – JAMA Otolaryngology – Head & Neck Surgery (free for a limited period)